Trial · NCT04064346
Participant flow63
How many started, completed or left each group, period by period.
1 to 20 of 63
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Pre-randomization Single-blind Period | STARTED | All Subjects Pre-randomization | 12 | |
| Pre-randomization Single-blind Period | STARTED | Lixivaptan | 0 | |
| Pre-randomization Single-blind Period | STARTED | Placebo | 0 | |
| Pre-randomization Single-blind Period | Treated in Placebo Run-in | All Subjects Pre-randomization | 12 | |
| Pre-randomization Single-blind Period | Treated in Placebo Run-in | Lixivaptan | 0 | |
| Pre-randomization Single-blind Period | Treated in Placebo Run-in | Placebo | 0 | |
| Pre-randomization Single-blind Period | Treated in Lixivaptan Titration Period | All Subjects Pre-randomization | 8 | |
| Pre-randomization Single-blind Period | Treated in Lixivaptan Titration Period | Lixivaptan | 0 | |
| Pre-randomization Single-blind Period | Treated in Lixivaptan Titration Period | Placebo | 0 | |
| Pre-randomization Single-blind Period | COMPLETED | All Subjects Pre-randomization | 5 | |
| Pre-randomization Single-blind Period | COMPLETED | Lixivaptan | 0 | |
| Pre-randomization Single-blind Period | COMPLETED | Placebo | 0 | |
| Pre-randomization Single-blind Period | NOT COMPLETED | All Subjects Pre-randomization | 7 | |
| Pre-randomization Single-blind Period | NOT COMPLETED | Lixivaptan | 0 | |
| Pre-randomization Single-blind Period | NOT COMPLETED | Placebo | 0 | |
| Randomized Double-blind Period | STARTED | All Subjects Pre-randomization | 0 | |
| Randomized Double-blind Period | STARTED | Lixivaptan | 4 | |
| Randomized Double-blind Period | STARTED | Placebo | 1 | |
| Randomized Double-blind Period | Randomized | All Subjects Pre-randomization | 0 | |
| Randomized Double-blind Period | Randomized | Lixivaptan | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04064346/flow